查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1856330

血液採集設備市場按產品類型、技術、材料、應用和最終用戶分類 - 全球預測 2025-2032

Blood Collection Devices Market by Product Type, Technology, Material, Application, End Users - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 192 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，血液採集設備市場規模將達到 124.3 億美元，複合年成長率為 6.09%。

關鍵市場統計數據
基準年 2024 77.4億美元
預計年份：2025年 81.8億美元
預測年份 2032 124.3億美元
複合年成長率 (%) 6.09%

一份關於血液採集設備生態系統的全面發展方向報告，涵蓋臨床促進因素、監管要求、生產製造複雜性以及策略重點。

血液採集設備領域處於臨床需求、監管環境和製造複雜性的交會點，因此創新與可靠性必須並存。診斷技術的進步、對病人安全的日益重視以及醫療服務模式的轉變，都提升了能夠可靠採集和儲存生物檢體的設備的重要性。因此，價值鏈上的相關人員——製造商、臨床實驗室、採購人員和醫療服務提供者——都必須應對不斷變化的技術標準、材料選擇和營運預期。

對影響醫療設備設計、監管預期、供應鏈韌性和永續性優先事項的變革力量進行策略性檢驗

近年來，一場變革性的轉變正在再形成血液採集設備的設計、製造和在醫療點的應用方式。自動化、封閉式系統設計和整合分析降低了分析前變異性，同時提高了中心實驗室的偵測通量。同時，居家檢測和即時檢測的興起，也凸顯了對易於使用且穩定性強的設備的需求，迫使製造商重新思考人體工學和防腐劑的化學特性。

分析性地闡述了近期美國關稅政策如何改變了籌資策略、生產地點、採購合約和產品開發決策。

美國新關稅政策的實施將持續到2025年，對血液採集設備生態系統中的相關人員產生了多方面的影響，涵蓋供應鏈、採購決策和產品成本結構。短期來看，依賴進口原料和成品組件的製造商面臨到岸成本上漲的壓力，迫使他們重新談判供應商合約並重新評估生產佈局。這些成本動態促使採購團隊仔細檢視整體擁有成本（TCO），並評估近期價格調整是暫時的，還是預示著長期採購複雜性的體現。

透過深度細分主導的分析，揭示產品類型、技術選擇、材料選擇、臨床應用和最終用戶需求如何影響策略性產品和商業性決策。

這種深入的細分揭示了血液採集設備領域內不同產品類型和終端用戶需求所受到的獨特技術和商業性動態的影響。不同類型的產品在性能和監管方面各有側重。血液採集袋需要強大的防漏性能、檢驗的滅菌方法和安全的標籤系統。血液採集針需要穩定的穿刺性能和生物相容性塗層，而注射器針頭和真空針頭則各自具有獨特的操作和安全考慮。血液採集管涵蓋了EDTA、肝素、血漿和血清管等各種特殊配方和添加劑管理。採血採血針強調易用性、最大限度減少疼痛和安全處置。

本書從細緻的區域觀點，探討了美洲、歐洲、中東和非洲以及亞太地區的動態變化將如何影響採購、監管、生產製造和臨床應用。

區域動態持續影響全球血液採集設備市場的策略重點與競爭格局。在美洲，完善的捐血基礎設施、先進的實驗室網路和集中的採購管道，使得產品性能、可追溯性和供應商可靠性至關重要。該地區的醫療機構通常尋求能夠支援快速完成監管文件、完善上市後監測、庫存管理和臨床培訓的夥伴關係模式，並傾向於選擇能夠提供設備產品組合之外的綜合服務的供應商。

競爭行為的策略整合表明，創新、監管掌控、供應鏈控制和服務差異化如何決定領導力和韌性。

主要企業之間的競爭源自於產品創新、監管專業知識、供應鏈控制以及超越設備本身的附加價值服務的綜合作用。市場領導企業正投資於自動化平台和整合數位解決方案，以增強分析前可追溯性和實驗室工作流程，而專業公司則專注於小眾產品的卓越表現，例如新型試管化學配方或符合人體工學的採血針系統，以解決特定的臨床痛點。設備製造商和診斷設備供應商之間的策略聯盟日益普遍，從而能夠提供捆綁式服務，最佳化從樣本到結果的整個流程。

一系列切實可行的策略行動，高階主管可以採取這些行動來增強供應鏈韌性、加速創新應用、提高監管應對力並鞏固基於服務的差異化優勢。

為維持成長並降低風險，產業領導者應採取協調一致的行動，將產品創新、供應鏈韌性和商業性執行結合。首先，透過對多家供應商進行資格認證並開發區域製造方案，實現籌資策略多元化，降低貿易中斷和關稅波動帶來的風險。投資短期雙重採購和策略性庫存緩衝，可在實施長期在地化計畫的同時保障業務連續性。其次，在臨床和營運效益足以支持資本投入的情況下，加速採用自動化和封閉式系統設計，同時在低產量或分散式環境中提供經濟高效的人工替代方案。

透明的調查方法概述：描述了支撐分析的關鍵相關人員參與、二次綜合、三角驗證實踐和品質保證流程。

本分析所依據的研究結合了與相關人員的質性訪談、嚴謹的二手資料綜合分析和資料三角驗證，以確保獲得平衡且切實可行的洞見。主要研究包括對臨床實驗室負責人、採購負責人、製造企業高管和法規事務專家進行結構化訪談，以獲取關於設備性能、採購限制和市場推廣促進因素的第一手觀點。這些訪談最終形成了一個產品類型、技術、材料、應用和最終用途的分類體系，從而能夠進行反映實際業務狀況的針對性分析。

這份簡潔的報告綜合闡述了策略重點、營運要務和精闢結論，明確了在整個生態系統中實現臨床和商業性價值所需的行動。

摘要：在技術創新、不斷變化的監管環境和供應鏈動態的驅動下，血液採集設備市場正經歷顯著的變革時期。這些因素正在再形成產品設計重點，加速高產量製造環境中自動化技術的應用，並凸顯在貿易政策變化背景下，制定具有韌性的籌資策略的重要性。同時，根據產品類型、技術、材料、臨床用途和最終用戶背景進行細緻的市場細分，需要一種兼顧性能、成本和合規性的客製化方法。

目錄

第1章：序言

第2章調查方法

第3章執行摘要

第4章 市場概覽

第5章 市場洞察

  • 採用封閉式採血裝置，最大限度地降低污染風險，確保樣本完整性
  • 將RFID技術與智慧採血管整合，實現樣本的自動化追蹤與溯源
  • 開發一種超低容量兒科採血裝置，以減少患者不適和樣本浪費。
  • 利用微流體技術實現無針採血系統的興起，可實現無痛採樣。
  • 新冠病毒抗原和抗體血液採集試劑盒需求的成長推動了就地檢驗的需求。
  • 利用家用採血設備和遠端醫療整合技術的遠端患者監護解決方案日益普及
  • 監管機構對靜脈採血安全和針刺預防日益重視，推動了器械創新。
  • 生物銀行計畫的擴展刺激了高通量血液採集自動化解決方案的需求。

第6章美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章 依產品類型分類的血液採集設備市場

  • 血袋
  • 採血針
    • 針頭
    • 真空針
  • 採血管
    • EDTA管
    • 肝素管
    • 電漿管
    • 血清管
  • 採血採血針

9. 按技術分類的採血設備市場

  • 自動採血裝置
  • 手動採血裝置

第10章 依材料分類的採血設備市場

  • 玻璃
  • 塑膠
  • 橡皮
  • 不銹鋼

第11章 依應用分類的採血設備市場

  • 診斷
  • 治療

第12章 依最終用戶分類的血液採集設備市場

  • 捐血中心
  • 診斷中心和病理實驗室
  • 醫院和診所

第13章 各地區血液採集設備市場

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第14章 按組別分類的採血設備市場

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第15章 各國血液採集設備市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第16章 競爭格局

  • 2024年市佔率分析
  • FPNV定位矩陣，2024
  • 競爭分析
    • Abbott Laboratories
    • AdvaCare Pharma
    • Avanos Medical, Inc.
    • Avantor, Inc.
    • B. Braun SE
    • Becton, Dickinson and Company
    • Bio-Rad Laboratories, Inc.
    • Biosigma SpA
    • Cardinal Health, Inc.
    • Exelint International, Co.
    • Fresenius SE & Co. KGaA
    • Greiner AG
    • Haemonetics Corporation by GVS SpA
    • ICU Medical, Inc.
    • Kawasumi Laboratories America, Inc.
    • Lasany International
    • Medtronic PLC
    • Merit Medical Systems, Inc.
    • Nipro Corporation
    • Sarstedt AG & Co. KG
    • Sekisui Medical Co., Ltd.
    • Siemens Healthineers AG
    • Terumo Corporation
    • Thermo Fisher Scientific Inc.
Product Code: MRR-742BD517BE69

The Blood Collection Devices Market is projected to grow by USD 12.43 billion at a CAGR of 6.09% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 7.74 billion
Estimated Year [2025] USD 8.18 billion
Forecast Year [2032] USD 12.43 billion
CAGR (%) 6.09%

A comprehensive orientation to the blood collection device ecosystem that frames clinical drivers, regulatory demands, manufacturing complexity and strategic priorities

The blood collection device arena sits at the intersection of clinical need, regulatory scrutiny, and manufacturing complexity, creating a landscape where innovation and reliability must coexist. Advances in diagnostics, the growing emphasis on patient safety, and shifts in healthcare delivery models are elevating the strategic importance of devices that reliably obtain and preserve biological specimens. Consequently, stakeholders across the value chain-manufacturers, clinical laboratories, procurement professionals, and healthcare providers-must navigate evolving technical standards, material choices, and operational expectations.

Transitioning from traditional supply paradigms, industry participants are responding to demands for higher throughput, more consistent sample integrity, and enhanced user safety. Simultaneously, environmental considerations and circularity targets are prompting re-evaluation of materials and single-use formats. These combined pressures require organizations to balance short-term operational continuity with long-term strategic investments in automation, supply resilience, and regulatory preparedness. The introduction lays the groundwork for deeper analysis by framing the core drivers, risk vectors, and value opportunities that shape decision-making for manufacturers and institutional buyers alike.

A strategic examination of the transformative forces reshaping device design, regulatory expectations, supply chain resilience and sustainability priorities

Recent years have produced transformational shifts that are reshaping how blood collection devices are designed, manufactured, and deployed across care settings. Technological convergence is particularly notable: automation, closed-system designs, and integrated analytics are reducing pre-analytical variability while enabling higher throughput in centralized laboratories. At the same time, the rise of home-collection and point-of-care testing has amplified the need for user-friendly devices and robust stability profiles, prompting manufacturers to rethink ergonomics and preservative chemistry.

Regulatory and policy shifts are also catalyzing change. Heightened attention to adverse events, traceability requirements, and sterilization documentation has driven stronger post-market surveillance and more rigorous design controls. In parallel, supply chain realignment-motivated by both geopolitical uncertainty and a desire for regional self-sufficiency-has encouraged investments in localized manufacturing and dual-sourcing strategies. Moreover, sustainability commitments from hospitals and procurement consortia are influencing material selection and end-of-life considerations, nudging the industry toward alternatives to traditional plastics and greater use of recyclable or lower-impact components.

Together, these disruptive forces are fostering a competitive environment where speed to regulatory approval, the ability to demonstrate reliable clinical performance, and resilience of supply chains determine which companies will lead the next phase of industry evolution. As a result, organizations that integrate technological innovation with pragmatic supply and regulatory strategies are positioned to capture expanded clinical adoption and strengthen customer trust.

An analytical narrative on how recent United States tariff policies have reshaped sourcing strategies, production footprints, procurement contracts and product development decisions

The introduction of new tariff measures in the United States during 2025 has exerted layered effects across supply chains, procurement decisions, and product cost structures for stakeholders in the blood collection device ecosystem. In the immediate term, manufacturers that rely on imported raw materials or finished components experienced upward pressure on landed costs, which necessitated renegotiation of supplier contracts and reassessment of production footprints. These cost dynamics encouraged procurement teams to scrutinize total cost of ownership more closely, evaluating whether near-term price adjustments were temporary or indicative of longer-term sourcing complexity.

In response, many organizations accelerated diversification strategies by qualifying secondary suppliers, increasing inventory buffers for critical items, and exploring regional manufacturing partnerships that reduce exposure to cross-border duties. This strategic pivot carried operational trade-offs: while localization can mitigate tariff exposure, it may require significant capital expenditure or compromise on supplier specialization. Over time, the tariff environment also influenced product development decisions, encouraging designs that minimize reliance on imported subassemblies and that favor materials available from domestic or allied sources.

From a commercial perspective, buyers adjusted tender frameworks and procurement schedules to maintain supply continuity and price predictability. Meanwhile, companies with vertically integrated capabilities or established regional manufacturing hubs found opportunities to strengthen customer relationships by offering more predictable lead times and simplified compliance documentation. Looking ahead, the cumulative impacts of tariff-driven adjustments reinforce the importance of adaptable sourcing policies and proactive engagement with procurement partners to sustain margins and service levels in a shifting trade environment.

A deep segmentation-led analysis revealing how product types, technology choices, material selections, clinical applications and end-user needs shape strategic product and commercial decisions

Insightful segmentation illuminates the distinct technical and commercial dynamics that govern different product categories and end-user needs within the blood collection device space. Product type distinctions reveal divergent performance and regulatory priorities: Blood Bags require robust leak resistance, validated sterilization approaches, and secure labeling systems; Blood Collection Needles demand consistent puncture performance and biocompatible finishes, with syringe needles and vacuum needles each presenting unique handling and safety considerations; Blood Collection Tubes encompass specialized formulations and additive management across EDTA tubes, Heparin tubes, Plasma Blood tubes, and Serum tubes; and Blood Lancets emphasize ease of use, minimized pain, and safe disposal.

Technology segmentation differentiates opportunities and adoption pathways across automated blood collection devices and manual blood collection devices. Automation appeals to high-throughput laboratories and centralized blood banks seeking reduced variability and enhanced traceability, whereas manual devices remain prevalent in decentralized settings, smaller clinics, and certain point-of-care scenarios where cost and simplicity drive selection. Material choices further nuance product strategies, as glass offers inert properties ideal for some analytical workflows while plastic provides weight, breakage resistance, and cost advantages; rubber components influence sealing integrity and shelf life; and stainless steel dominates sharps that require precise machining and corrosion resistance.

Application-oriented segmentation separates diagnostic and therapeutic use cases, each imposing different validation, handling, and stability requirements. Diagnostics prioritize pre-analytical integrity and compatibility with downstream assays, while therapeutic applications may require specialized storage, compatibility with transfusion workflows, and traceability for clinical interventions. Finally, end-user segmentation-spanning blood donation centers, diagnostic centers and pathology laboratories, and hospitals and clinics-drives procurement patterns, capital allocation, and service-level demands. Blood donation centers prioritize donor safety and throughput, diagnostic centers emphasize compatibility with laboratory analyzers and sample stability, and hospitals and clinics require versatile devices that support a wide range of clinical procedures. Recognizing these layered segment distinctions helps firms tailor product portfolios, quality systems, and commercial approaches to address specific clinical, regulatory, and operational requirements effectively.

A nuanced regional perspective on how the Americas, Europe Middle East and Africa, and Asia-Pacific dynamics influence procurement, regulation, manufacturing and clinical adoption

Regional dynamics continue to influence strategic priorities and competitive positioning across the global landscape for blood collection devices. In the Americas, established blood donation infrastructures, sophisticated laboratory networks, and concentrated procurement channels create an environment where product performance, traceability, and supplier reliability are paramount. Providers in this region often demand rapid regulatory documentation, robust post-market surveillance, and partnership models that support inventory management and clinical training, which favors suppliers capable of delivering comprehensive service offerings alongside device portfolios.

Across Europe, the Middle East and Africa, regulatory heterogeneity and diverse healthcare delivery models produce a wide range of adoption curves and procurement behaviors. Western European markets emphasize stringent conformity assessment and environmental compliance, incentivizing premium devices and strong supplier certification paths. Meanwhile, markets within the broader region may prioritize cost-effective solutions and adaptable supply arrangements, and this diversity requires manufacturers to adopt flexible commercial strategies and regional regulatory expertise. Transitional healthcare systems in parts of the region present opportunities for targeted investments in training, supply chain development, and localized product customization.

The Asia-Pacific region exhibits rapid uptake of both centralized laboratory automation and decentralized testing models, driven by expanding healthcare access, rising screening initiatives, and growing local manufacturing capacity. Producers and distributors in Asia-Pacific are increasingly focused on scalability, cost-competitive manufacturing, and the ability to meet diverse regulatory regimes quickly. Additionally, Asia-Pacific serves as a critical production hub for many global players, and regional policies that encourage domestic manufacturing have prompted investments in capacity expansion, creating interdependencies between trade policies and supply availability worldwide. Together, these regional characteristics inform differentiated go-to-market tactics, regulatory planning, and manufacturing investments.

A strategic synthesis of competitive behavior showing how innovation, regulatory mastery, supply chain control and services-based differentiation determine leadership and resilience

Competitive dynamics among leading companies are driven by a combination of product innovation, regulatory expertise, supply chain control, and value-added services that extend beyond the device itself. Market leaders are investing in automation platforms and integrated digital solutions that enhance pre-analytical traceability and laboratory workflows, while specialized players focus on niche product excellence-such as novel tube chemistries or ergonomic lancet systems-that solve specific clinical pain points. Strategic partnerships between device manufacturers and diagnostic instrument providers are increasingly common, enabling bundled offerings that optimize sample-to-result pathways.

Consolidation activity and strategic alliances reflect a drive to capture complementary capabilities, scale regulatory operations, and secure supplier networks. In parallel, a subset of companies pursues regional manufacturing investments to reduce trade exposure and accelerate product registration, while others prioritize strengthening aftermarket services, including training, technical support, and consumable replenishment programs that increase customer stickiness. Product differentiation often hinges on documented stability claims, sterilization validation, and quality management certifications, which inform procurement decisions and reimbursement conversations. Ultimately, firms that align innovation with operational excellence and robust regulatory pathways are positioned to deepen market penetration and foster long-term customer partnerships.

A practical set of strategic actions for executives to strengthen supply resilience, accelerate innovation adoption, elevate regulatory readiness and embed services-based differentiation

Industry leaders should pursue coordinated actions that align product innovation, supply resilience, and commercial execution to sustain growth and mitigate risk. First, diversify sourcing strategies by qualifying multiple suppliers and developing regional manufacturing options to reduce exposure to trade disruptions and tariff volatility. Investing in near-term dual sourcing and strategic inventory buffers can protect continuity while longer-term localization plans are implemented. Second, accelerate adoption of automation and closed-system designs where clinical and operational benefits justify capital allocation, while simultaneously offering cost-effective manual alternatives for low-volume or decentralized settings.

Third, prioritize material innovation and sustainability by evaluating alternatives that preserve analytical integrity while reducing environmental impact; engage with lifecycle assessment frameworks to demonstrate value to procurement partners. Fourth, enhance regulatory readiness through proactive engagement with authorities, strengthened post-market surveillance, and expedited pathways for clearance or conformity assessment, thereby shortening time-to-adoption in regulated markets. Fifth, embed commercial support services-training, technical assistance, and consumables management-into customer contracts to differentiate offerings and improve retention. Finally, align R&D investments with real-world clinical needs by co-developing solutions with leading laboratories and healthcare providers, ensuring product designs reflect end-user workflows and deliver demonstrable improvements in sample quality and patient safety. Taken together, these steps will help organizations convert insight into operational advantage and durable customer relationships.

A transparent methodological overview explaining primary stakeholder engagement, secondary synthesis, triangulation practices and quality assurance processes that underpin the analysis

The research underpinning this analysis combined qualitative stakeholder engagement with rigorous secondary synthesis and data triangulation to ensure balanced, actionable insights. Primary research included structured interviews with clinical laboratory leaders, procurement officers, manufacturing executives, and regulatory affairs specialists to capture first-hand perspectives on device performance, sourcing constraints, and adoption drivers. These conversations informed the taxonomy used to disaggregate product types, technologies, materials, applications, and end-user contexts, enabling targeted analysis that reflects operational realities.

Secondary sources were reviewed to contextualize regulatory trends, material science developments, and trade policy impacts, with careful attention to public regulatory documents, standards bodies publications, and peer-reviewed clinical literature. Triangulation techniques were applied to reconcile differing viewpoints and validate key conclusions, while sensitivity checks were used to surface alternative interpretations. Quality assurance processes included expert peer review and internal methodological audits to confirm consistency in definitions, inclusion criteria, and analytical logic. The research acknowledges limitations inherent to rapidly changing policy environments and heterogeneous regional data, and therefore emphasizes scenario-based insights and actionable recommendations rather than precise numerical projections.

A concise concluding synthesis that crystallizes strategic priorities, operational imperatives and the actions needed to realize clinical and commercial value across the ecosystem

In summary, the blood collection device landscape is undergoing meaningful transformation driven by technological innovation, heightened regulatory expectations, and evolving supply chain dynamics. These forces are reshaping product design priorities, accelerating adoption of automation in high-volume settings, and elevating the importance of resilient sourcing strategies in the face of trade policy shifts. At the same time, segmentation nuances-across product types, technologies, materials, clinical applications, and end-user contexts-underscore the need for tailored approaches that balance performance, cost, and compliance.

Organizations that proactively align R&D, manufacturing strategy, and commercial support models will be better positioned to meet clinical needs and navigate regulatory complexity. Leaders should prioritize supply diversification, invest in automation where appropriate, pursue sustainable material pathways, and strengthen regulatory engagement to accelerate access. By translating these insights into concrete actions, manufacturers and institutional buyers can improve operational continuity, enhance sample integrity, and deliver measurable clinical value. The conclusion invites decision-makers to use these findings to inform strategic planning and to mobilize resources that capitalize on emerging opportunities while managing downside risks effectively.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Adoption of closed system blood collection devices to minimize contamination risk and ensure sample integrity
  • 5.2. Integration of smart blood collection tubes with RFID technology for automated sample tracking and traceability
  • 5.3. Development of ultra-low volume pediatric blood collection devices to reduce patient discomfort and sample waste
  • 5.4. Rise of needle-free blood collection systems leveraging microfluidic technologies for pain-free sampling
  • 5.5. Growth in COVID-19 antigen and antibody blood collection kits driving demand for point-of-care testing
  • 5.6. Surge in remote patient monitoring solutions using at-home blood collection devices and telehealth integration
  • 5.7. Increasing regulatory focus on phlebotomy safety and needlestick prevention driving device innovation
  • 5.8. Expansion of biobanking initiatives spurring demand for high-throughput blood collection automation solutions

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Blood Collection Devices Market, by Product Type

  • 8.1. Blood Bags
  • 8.2. Blood Collection Needles
    • 8.2.1. Syringe Needles
    • 8.2.2. Vacuum Needles
  • 8.3. Blood Collection Tubes
    • 8.3.1. EDTA Tubes
    • 8.3.2. Heparin Tubes
    • 8.3.3. Plasma Blood Tubes
    • 8.3.4. Serum Tubes
  • 8.4. Blood Lancets

9. Blood Collection Devices Market, by Technology

  • 9.1. Automated Blood Collection Devices
  • 9.2. Manual Blood Collection Devices

10. Blood Collection Devices Market, by Material

  • 10.1. Glass
  • 10.2. Plastic
  • 10.3. Rubber
  • 10.4. Stainless Steel

11. Blood Collection Devices Market, by Application

  • 11.1. Diagnostics
  • 11.2. Therapeutics

12. Blood Collection Devices Market, by End Users

  • 12.1. Blood Donation Centers
  • 12.2. Diagnostic Centers & Pathology Laboratory
  • 12.3. Hospitals & Clinics

13. Blood Collection Devices Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Blood Collection Devices Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Blood Collection Devices Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. Competitive Landscape

  • 16.1. Market Share Analysis, 2024
  • 16.2. FPNV Positioning Matrix, 2024
  • 16.3. Competitive Analysis
    • 16.3.1. Abbott Laboratories
    • 16.3.2. AdvaCare Pharma
    • 16.3.3. Avanos Medical, Inc.
    • 16.3.4. Avantor, Inc.
    • 16.3.5. B. Braun SE
    • 16.3.6. Becton, Dickinson and Company
    • 16.3.7. Bio-Rad Laboratories, Inc.
    • 16.3.8. Biosigma S.p.A.
    • 16.3.9. Cardinal Health, Inc.
    • 16.3.10. Exelint International, Co.
    • 16.3.11. Fresenius SE & Co. KGaA
    • 16.3.12. Greiner AG
    • 16.3.13. Haemonetics Corporation by GVS S.p.A.
    • 16.3.14. ICU Medical, Inc.
    • 16.3.15. Kawasumi Laboratories America, Inc.
    • 16.3.16. Lasany International
    • 16.3.17. Medtronic PLC
    • 16.3.18. Merit Medical Systems, Inc.
    • 16.3.19. Nipro Corporation
    • 16.3.20. Sarstedt AG & Co. KG
    • 16.3.21. Sekisui Medical Co., Ltd.
    • 16.3.22. Siemens Healthineers AG
    • 16.3.23. Terumo Corporation
    • 16.3.24. Thermo Fisher Scientific Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY TECHNOLOGY, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY MATERIAL, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY MATERIAL, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY END USERS, 2024 VS 2032 (%)
  • FIGURE 11. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY END USERS, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 13. AMERICAS BLOOD COLLECTION DEVICES MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. NORTH AMERICA BLOOD COLLECTION DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. LATIN AMERICA BLOOD COLLECTION DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA BLOOD COLLECTION DEVICES MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. EUROPE BLOOD COLLECTION DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. MIDDLE EAST BLOOD COLLECTION DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. AFRICA BLOOD COLLECTION DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. ASIA-PACIFIC BLOOD COLLECTION DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. ASEAN BLOOD COLLECTION DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. GCC BLOOD COLLECTION DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. EUROPEAN UNION BLOOD COLLECTION DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. BRICS BLOOD COLLECTION DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. G7 BLOOD COLLECTION DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. NATO BLOOD COLLECTION DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 28. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 29. BLOOD COLLECTION DEVICES MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 30. BLOOD COLLECTION DEVICES MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. BLOOD COLLECTION DEVICES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY BLOOD BAGS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY BLOOD BAGS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY BLOOD BAGS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY BLOOD BAGS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY BLOOD BAGS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY BLOOD BAGS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY BLOOD COLLECTION NEEDLES, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY BLOOD COLLECTION NEEDLES, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY BLOOD COLLECTION NEEDLES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY BLOOD COLLECTION NEEDLES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY BLOOD COLLECTION NEEDLES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY BLOOD COLLECTION NEEDLES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY BLOOD COLLECTION NEEDLES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY BLOOD COLLECTION NEEDLES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY SYRINGE NEEDLES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY SYRINGE NEEDLES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY SYRINGE NEEDLES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY SYRINGE NEEDLES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY SYRINGE NEEDLES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY SYRINGE NEEDLES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY VACUUM NEEDLES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY VACUUM NEEDLES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY VACUUM NEEDLES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY VACUUM NEEDLES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY VACUUM NEEDLES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY VACUUM NEEDLES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY BLOOD COLLECTION TUBES, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY BLOOD COLLECTION TUBES, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY BLOOD COLLECTION TUBES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY BLOOD COLLECTION TUBES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY BLOOD COLLECTION TUBES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY BLOOD COLLECTION TUBES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY BLOOD COLLECTION TUBES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY BLOOD COLLECTION TUBES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY EDTA TUBES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY EDTA TUBES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY EDTA TUBES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY EDTA TUBES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY EDTA TUBES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY EDTA TUBES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY HEPARIN TUBES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY HEPARIN TUBES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY HEPARIN TUBES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY HEPARIN TUBES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY HEPARIN TUBES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY HEPARIN TUBES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY PLASMA BLOOD TUBES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY PLASMA BLOOD TUBES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY PLASMA BLOOD TUBES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY PLASMA BLOOD TUBES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY PLASMA BLOOD TUBES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY PLASMA BLOOD TUBES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY SERUM TUBES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY SERUM TUBES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY SERUM TUBES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY SERUM TUBES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY SERUM TUBES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY SERUM TUBES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY BLOOD LANCETS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY BLOOD LANCETS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY BLOOD LANCETS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY BLOOD LANCETS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY BLOOD LANCETS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY BLOOD LANCETS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY AUTOMATED BLOOD COLLECTION DEVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY AUTOMATED BLOOD COLLECTION DEVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY AUTOMATED BLOOD COLLECTION DEVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY AUTOMATED BLOOD COLLECTION DEVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY AUTOMATED BLOOD COLLECTION DEVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY AUTOMATED BLOOD COLLECTION DEVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY MANUAL BLOOD COLLECTION DEVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY MANUAL BLOOD COLLECTION DEVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY MANUAL BLOOD COLLECTION DEVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY MANUAL BLOOD COLLECTION DEVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY MANUAL BLOOD COLLECTION DEVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY MANUAL BLOOD COLLECTION DEVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY GLASS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY GLASS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY GLASS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY GLASS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY GLASS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY GLASS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY PLASTIC, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY PLASTIC, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY PLASTIC, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY PLASTIC, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY PLASTIC, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY PLASTIC, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY RUBBER, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY RUBBER, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY RUBBER, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY RUBBER, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY RUBBER, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY RUBBER, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY STAINLESS STEEL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY STAINLESS STEEL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY STAINLESS STEEL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY STAINLESS STEEL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY STAINLESS STEEL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY STAINLESS STEEL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY DIAGNOSTICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY DIAGNOSTICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY DIAGNOSTICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY DIAGNOSTICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY DIAGNOSTICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY DIAGNOSTICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY THERAPEUTICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY THERAPEUTICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY THERAPEUTICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY THERAPEUTICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY THERAPEUTICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY THERAPEUTICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY END USERS, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY END USERS, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY BLOOD DONATION CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY BLOOD DONATION CENTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY BLOOD DONATION CENTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY BLOOD DONATION CENTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY BLOOD DONATION CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY BLOOD DONATION CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY DIAGNOSTIC CENTERS & PATHOLOGY LABORATORY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY DIAGNOSTIC CENTERS & PATHOLOGY LABORATORY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY DIAGNOSTIC CENTERS & PATHOLOGY LABORATORY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY DIAGNOSTIC CENTERS & PATHOLOGY LABORATORY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 137. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY DIAGNOSTIC CENTERS & PATHOLOGY LABORATORY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY DIAGNOSTIC CENTERS & PATHOLOGY LABORATORY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 139. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 140. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 141. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY HOSPITALS & CLINICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 142. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY HOSPITALS & CLINICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 143. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY HOSPITALS & CLINICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 144. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY HOSPITALS & CLINICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 145. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 146. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 147. AMERICAS BLOOD COLLECTION DEVICES MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 148. AMERICAS BLOOD COLLECTION DEVICES MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 149. AMERICAS BLOOD COLLECTION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 150. AMERICAS BLOOD COLLECTION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 151. AMERICAS BLOOD COLLECTION DEVICES MARKET SIZE, BY BLOOD COLLECTION NEEDLES, 2018-2024 (USD MILLION)
  • TABLE 152. AMERICAS BLOOD COLLECTION DEVICES MARKET SIZE, BY BLOOD COLLECTION NEEDLES, 2025-2032 (USD MILLION)
  • TABLE 153. AMERICAS BLOOD COLLECTION DEVICES MARKET SIZE, BY BLOOD COLLECTION TUBES, 2018-2024 (USD MILLION)
  • TABLE 154. AMERICAS BLOOD COLLECTION DEVICES MARKET SIZE, BY BLOOD COLLECTION TUBES, 2025-2032 (USD MILLION)
  • TABLE 155. AMERICAS BLOOD COLLECTION DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 156. AMERICAS BLOOD COLLECTION DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 157. AMERICAS BLOOD COLLECTION DEVICES MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 158. AMERICAS BLOOD COLLECTION DEVICES MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 159. AMERICAS BLOOD COLLECTION DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 160. AMERICAS BLOOD COLLECTION DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 161. AMERICAS BLOOD COLLECTION DEVICES MARKET SIZE, BY END USERS, 2018-2024 (USD MILLION)
  • TABLE 162. AMERICAS BLOOD COLLECTION DEVICES MARKET SIZE, BY END USERS, 2025-2032 (USD MILLION)
  • TABLE 163. NORTH AMERICA BLOOD COLLECTION DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 164. NORTH AMERICA BLOOD COLLECTION DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 165. NORTH AMERICA BLOOD COLLECTION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 166. NORTH AMERICA BLOOD COLLECTION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 167. NORTH AMERICA BLOOD COLLECTION DEVICES MARKET SIZE, BY BLOOD COLLECTION NEEDLES, 2018-2024 (USD MILLION)
  • TABLE 168. NORTH AMERICA BLOOD COLLECTION DEVICES MARKET SIZE, BY BLOOD COLLECTION NEEDLES, 2025-2032 (USD MILLION)
  • TABLE 169. NORTH AMERICA BLOOD COLLECTION DEVICES MARKET SIZE, BY BLOOD COLLECTION TUBES, 2018-2024 (USD MILLION)
  • TABLE 170. NORTH AMERICA BLOOD COLLECTION DEVICES MARKET SIZE, BY BLOOD COLLECTION TUBES, 2025-2032 (USD MILLION)
  • TABLE 171. NORTH AMERICA BLOOD COLLECTION DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 172. NORTH AMERICA BLOOD COLLECTION DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 173. NORTH AMERICA BLOOD COLLECTION DEVICES MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 174. NORTH AMERICA BLOOD COLLECTION DEVICES MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 175. NORTH AMERICA BLOOD COLLECTION DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 176. NORTH AMERICA BLOOD COLLECTION DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 177. NORTH AMERICA BLOOD COLLECTION DEVICES MARKET SIZE, BY END USERS, 2018-2024 (USD MILLION)
  • TABLE 178. NORTH AMERICA BLOOD COLLECTION DEVICES MARKET SIZE, BY END USERS, 2025-2032 (USD MILLION)
  • TABLE 179. LATIN AMERICA BLOOD COLLECTION DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 180. LATIN AMERICA BLOOD COLLECTION DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 181. LATIN AMERICA BLOOD COLLECTION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 182. LATIN AMERICA BLOOD COLLECTION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 183. LATIN AMERICA BLOOD COLLECTION DEVICES MARKET SIZE, BY BLOOD COLLECTION NEEDLES, 2018-2024 (USD MILLION)
  • TABLE 184. LATIN AMERICA BLOOD COLLECTION DEVICES MARKET SIZE, BY BLOOD COLLECTION NEEDLES, 2025-2032 (USD MILLION)
  • TABLE 185. LATIN AMERICA BLOOD COLLECTION DEVICES MARKET SIZE, BY BLOOD COLLECTION TUBES, 2018-2024 (USD MILLION)
  • TABLE 186. LATIN AMERICA BLOOD COLLECTION DEVICES MARKET SIZE, BY BLOOD COLLECTION TUBES, 2025-2032 (USD MILLION)
  • TABLE 187. LATIN AMERICA BLOOD COLLECTION DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 188. LATIN AMERICA BLOOD COLLECTION DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 189. LATIN AMERICA BLOOD COLLECTION DEVICES MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 190. LATIN AMERICA BLOOD COLLECTION DEVICES MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 191. LATIN AMERICA BLOOD COLLECTION DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 192. LATIN AMERICA BLOOD COLLECTION DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 193. LATIN AMERICA BLOOD COLLECTION DEVICES MARKET SIZE, BY END USERS, 2018-2024 (USD MILLION)
  • TABLE 194. LATIN AMERICA BLOOD COLLECTION DEVICES MARKET SIZE, BY END USERS, 2025-2032 (USD MILLION)
  • TABLE 195. EUROPE, MIDDLE EAST & AFRICA BLOOD COLLECTION DEVICES MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 196. EUROPE, MIDDLE EAST & AFRICA BLOOD COLLECTION DEVICES MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 197. EUROPE, MIDDLE EAST & AFRICA BLOOD COLLECTION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 198. EUROPE, MIDDLE EAST & AFRICA BLOOD COLLECTION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 199. EUROPE, MIDDLE EAST & AFRICA BLOOD COLLECTION DEVICES MARKET SIZE, BY BLOOD COLLECTION NEEDLES, 2018-2024 (USD MILLION)
  • TABLE 200. EUROPE, MIDDLE EAST & AFRICA BLOOD COLLECTION DEVICES MARKET SIZE, BY BLOOD COLLECTION NEEDLES, 2025-2032 (USD MILLION)
  • TABLE 201. EUROPE, MIDDLE EAST & AFRICA BLOOD COLLECTION DEVICES MARKET SIZE, BY BLOOD COLLECTION TUBES, 2018-2024 (USD MILLION)
  • TABLE 202. EUROPE, MIDDLE EAST & AFRICA BLOOD COLLECTION DEVICES MARKET SIZE, BY BLOOD COLLECTION TUBES, 2025-2032 (USD MILLION)
  • TABLE 203. EUROPE, MIDDLE EAST & AFRICA BLOOD COLLECTION DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 204. EUROPE, MIDDLE EAST & AFRICA BLOOD COLLECTION DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 205. EUROPE, MIDDLE EAST & AFRICA BLOOD COLLECTION DEVICES MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 206. EUROPE, MIDDLE EAST & AFRICA BLOOD COLLECTION DEVICES MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 207. EUROPE, MIDDLE EAST & AFRICA BLOOD COLLECTION DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 208. EUROPE, MIDDLE EAST & AFRICA BLOOD COLLECTION DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 209. EUROPE, MIDDLE EAST & AFRICA BLOOD COLLECTION DEVICES MARKET SIZE, BY END USERS, 2018-2024 (USD MILLION)
  • TABLE 210. EUROPE, MIDDLE EAST & AFRICA BLOOD COLLECTION DEVICES MARKET SIZE, BY END USERS, 2025-2032 (USD MILLION)
  • TABLE 211. EUROPE BLOOD COLLECTION DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 212. EUROPE BLOOD COLLECTION DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 213. EUROPE BLOOD COLLECTION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 214. EUROPE BLOOD COLLECTION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 215. EUROPE BLOOD COLLECTION DEVICES MARKET SIZE, BY BLOOD COLLECTION NEEDLES, 2018-2024 (USD MILLION)
  • TABLE 216. EUROPE BLOOD COLLECTION DEVICES MARKET SIZE, BY BLOOD COLLECTION NEEDLES, 2025-2032 (USD MILLION)
  • TABLE 217. EUROPE BLOOD COLLECTION DEVICES MARKET SIZE, BY BLOOD COLLECTION TUBES, 2018-2024 (USD MILLION)
  • TABLE 218. EUROPE BLOOD COLLECTION DEVICES MARKET SIZE, BY BLOOD COLLECTION TUBES, 2025-2032 (USD MILLION)
  • TABLE 219. EUROPE BLOOD COLLECTION DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 220. EUROPE BLOOD COLLECTION DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 221. EUROPE BLOOD COLLECTION DEVICES MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 222. EUROPE BLOOD COLLECTION DEVICES MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 223. EUROPE BLOOD COLLECTION DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 224. EUROPE BLOOD COLLECTION DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 225. EUROPE BLOOD COLLECTION DEVICES MARKET SIZE, BY END USERS, 2018-2024 (USD MILLION)
  • TABLE 226. EUROPE BLOOD COLLECTION DEVICES MARKET SIZE, BY END USERS, 2025-2032 (USD MILLION)
  • TABLE 227. MIDDLE EAST BLOOD COLLECTION DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 228. MIDDLE EAST BLOOD COLLECTION DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 229. MIDDLE EAST BLOOD COLLECTION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 230. MIDDLE EAST BLOOD COLLECTION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 231. MIDDLE EAST BLOOD COLLECTION DEVICES MARKET SIZE, BY BLOOD COLLECTION NEEDLES, 2018-2024 (USD MILLION)
  • TABLE 232. MIDDLE EAST BLOOD COLLECTION DEVICES MARKET SIZE, BY BLOOD COLLECTION NEEDLES, 2025-2032 (USD MILLION)
  • TABLE 233. MIDDLE EAST BLOOD COLLECTION DEVICES MARKET SIZE, BY BLOOD COLLECTION TUBES, 2018-2024 (USD MILLION)
  • TABLE 234. MIDDLE EAST BLOOD COLLECTION DEVICES MARKET SIZE, BY BLOOD COLLECTION TUBES, 2025-2032 (USD MILLION)
  • TABLE 235. MIDDLE EAST BLOOD COLLECTION DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 236. MIDDLE EAST BLOOD COLLECTION DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 237. MIDDLE EAST BLOOD COLLECTION DEVICES MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 238. MIDDLE EAST BLOOD COLLECTION DEVICES MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 239. MIDDLE EAST BLOOD COLLECTION DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 240. MIDDLE EAST BLOOD COLLECTION DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 241. MIDDLE EAST BLOOD COLLECTION DEVICES MARKET SIZE, BY END USERS, 2018-2024 (USD MILLION)
  • TABLE 242. MIDDLE EAST BLOOD COLLECTION DEVICES MARKET SIZE, BY END USERS, 2025-2032 (USD MILLION)
  • TABLE 243. AFRICA BLOOD COLLECTION DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 244. AFRICA BLOOD COLLECTION DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 245. AFRICA BLOOD COLLECTION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 246. AFRICA BLOOD COLLECTION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 247. AFRICA BLOOD COLLECTION DEVICES MARKET SIZE, BY BLOOD COLLECTION NEEDLES, 2018-2024 (USD MILLION)
  • TABLE 248. AFRICA BLOOD COLLECTION DEVICES MARKET SIZE, BY BLOOD COLLECTION NEEDLES, 2025-2032 (USD MILLION)
  • TABLE 249. AFRICA BLOOD COLLECTION DEVICES MARKET SIZE, BY BLOOD COLLECTION TUBES, 2018-2024 (USD MILLION)
  • TABLE 250. AFRICA BLOOD COLLECTION DEVICES MARKET SIZE, BY BLOOD COLLECTION TUBES, 2025-2032 (USD MILLION)
  • TABLE 251. AFRICA BLOOD COLLECTION DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 252. AFRICA BLOOD COLLECTION DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 253. AFRICA BLOOD COLLECTION DEVICES MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 254. AFRICA BLOOD COLLECTION DEVICES MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 255. AFRICA BLOOD COLLECTION DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 256. AFRICA BLOOD COLLECTION DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 257. AFRICA BLOOD COLLECTION DEVICES MARKET SIZE, BY END USERS, 2018-2024 (USD MILLION)
  • TABLE 258. AFRICA BLOOD COLLECTION DEVICES MARKET SIZE, BY END USERS, 2025-2032 (USD MILLION)
  • TABLE 259. ASIA-PACIFIC BLOOD COLLECTION DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 260. ASIA-PACIFIC BLOOD COLLECTION DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 261. ASIA-PACIFIC BLOOD COLLECTION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 262. ASIA-PACIFIC BLOOD COLLECTION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 263. ASIA-PACIFIC BLOOD COLLECTION DEVICES MARKET SIZE, BY BLOOD COLLECTION NEEDLES, 2018-2024 (USD MILLION)
  • TABLE 264. ASIA-PACIFIC BLOOD COLLECTION DEVICES MARKET SIZE, BY BLOOD COLLECTION NEEDLES, 2025-2032 (USD MILLION)
  • TABLE 265. ASIA-PACIFIC BLOOD COLLECTION DEVICES MARKET SIZE, BY BLOOD COLLECTION TUBES, 2018-2024 (USD MILLION)
  • TABLE 266. ASIA-PACIFIC BLOOD COLLECTION DEVICES MARKET SIZE, BY BLOOD COLLECTION TUBES, 2025-2032 (USD MILLION)
  • TABLE 267. ASIA-PACIFIC BLOOD COLLECTION DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 268. ASIA-PACIFIC BLOOD COLLECTION DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 269. ASIA-PACIFIC BLOOD COLLECTION DEVICES MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 270. ASIA-PACIFIC BLOOD COLLECTION DEVICES MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 271. ASIA-PACIFIC BLOOD COLLECTION DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 272. ASIA-PACIFIC BLOOD COLLECTION DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 273. ASIA-PACIFIC BLOOD COLLECTION DEVICES MARKET SIZE, BY END USERS, 2018-2024 (USD MILLION)
  • TABLE 274. ASIA-PACIFIC BLOOD COLLECTION DEVICES MARKET SIZE, BY END USERS, 2025-2032 (USD MILLION)
  • TABLE 275. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 276. GLOBAL BLOOD COLLECTION DEVICES MARKET SIZE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 277. ASEAN BLOOD COLLECTION DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 278. ASEAN BLOOD COLLECTION DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 279. ASEAN BLOOD COLLECTION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 280. ASEAN BLOOD COLLECTION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 281. ASEAN BLOOD COLLECTION DEVICES MARKET SIZE, BY BLOOD COLLECTION NEEDLES, 2018-2024 (USD MILLION)
  • TABLE 282. ASEAN BLOOD COLLECTION DEVICES MARKET SIZE, BY BLOOD COLLECTION NEEDLES, 2025-2032 (USD MILLION)
  • TABLE 283. ASEAN BLOOD COLLECTION DEVICES MARKET SIZE, BY BLOOD COLLECTION TUBES, 2018-2024 (USD MILLION)
  • TABLE 284. ASEAN BLOOD COLLECTION DEVICES MARKET SIZE, BY BLOOD COLLECTION TUBES, 2025-2032 (USD MILLION)
  • TABLE 285. ASEAN BLOOD COLLECTION DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 286. ASEAN BLOOD COLLECTION DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 287. ASEAN BLOOD COLLECTION DEVICES MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 288. ASEAN BLOOD COLLECTION DEVICES MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 289. ASEAN BLOOD COLLECTION DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 290. ASEAN BLOOD COLLECTION DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 291. ASEAN BLOOD COLLECTION DEVICES MARKET SIZE, BY END USERS, 2018-2024 (USD MILLION)
  • TABLE 292. ASEAN BLOOD COLLECTION DEVICES MARKET SIZE, BY END USERS, 2025-2032 (USD MILLION)
  • TABLE 293. GCC BLOOD COLLECTION DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 294. GCC BLOOD COLLECTION DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 295. GCC BLOOD COLLECTION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 296. GCC BLOOD COLLECTION DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 297. GCC BLOOD COLLECTION DEVICES MARKET SIZE, BY BLOOD COLLECTION NEEDLES, 2018-2024 (USD MILLION)
  • TABLE 298. GCC BLOOD COLLECTION DEVICES MARKET SIZE, BY BLOOD COLLECTION NEEDLES, 2025-2032 (USD MILLION)
  • TABLE 299. GCC BLOOD COLLECTION DEVICES MARKET SIZE, BY BLOOD COLLECTION TUBES, 2018-2024 (USD MILLION)
  • TABLE 300. GCC BLOOD COLLECTION DEVICES MARKET SIZE, BY BLOOD COLLECTION TUBES, 2025-2032 (USD MILLION)
  • TABLE 301. GCC BLOOD COLLECTION DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 302. GCC BLOOD COLLECTION DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 303. GCC BLOOD COLLECTION DEVICES MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 304. GCC BLOOD COLLECTION DEVICES MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 305. GCC BLOOD COLLECTION DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 306. GCC BLOOD COLLECTION DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 307. GCC BLOOD COLLECTION DEVICES MARKET SIZE, BY END USERS, 2018-2024 (USD MILLION)
  • TABLE 308. GCC BLOOD COLLECTION DEVICES MARKET SIZE, BY END USERS, 2025-2032 (USD MILLION)
  • TABLE 309. EUROPEAN UNION BLOOD COLLECTION DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 310. EUROPEAN UNION BLOOD COLLECTION DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 311. EUROPEAN UNION BLOOD COLLECTION